Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Clinical trial NCT06824181 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06824181
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-27
- Primary completion
- 2027-09-10
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.